Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
Myeloablative I-131-Tositumomab with Escalating Doses of Fludarabine and Autologous Hematopoietic Transplantation for Adults Age ≥ 60 Years with B Cell Lymphoma
Biology of Blood and Marrow Transplantation (2014)
  • Ajay K. Gopal, Fred Hutchinson Cancer Research Center
  • Ted A. Gooley, Fred Hutchinson Cancer Research Center
  • Joseph G. Rajendran, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Darrell R. Fisher, Pacific Northwest National Laboratory
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Ryan D. Cassaday, Fred Hutchinson Cancer Research Center
  • Andrew Shields, University of Washington
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
January 6, 2014
DOI
10.1016/j.bbmt.2014.02.004
Citation Information
Ajay K. Gopal, Ted A. Gooley, Joseph G. Rajendran, John M. Pagel, et al.. "Myeloablative I-131-Tositumomab with Escalating Doses of Fludarabine and Autologous Hematopoietic Transplantation for Adults Age ≥ 60 Years with B Cell Lymphoma" Biology of Blood and Marrow Transplantation Vol. 20 Iss. 6 (2014) p. 770 - 775
Available at: http://works.bepress.com/john-pagel/108/